Synjardy and Morphine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Synjardy (empagliflozin; metformin hydrochloride) and Morphine (morphine sulfate). Common drug interactions include acute pulmonary oedema among females and acne among males.

The phase IV clinical study analyzes what interactions people have when they take Synjardy and Morphine. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Synjardy?

Synjardy has active ingredients of empagliflozin; metformin hydrochloride. eHealthMe is studying from 2,928 Synjardy users. Check the latest studies of Synjardy.

What is Morphine?

Morphine has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 182,913 Morphine users. Check the latest studies of Morphine.



On Jul, 30, 2026

16 people who take Synjardy and Morphine together, and have interactions are studied.

Synjardy and Morphine drug interactions.

What are the common drug interactions of Synjardy and Morphine, by gender? *:

female:

  1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  2. Blood lactic acid increased
  3. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Respiratory tract infection
  6. Vomiting

male:

  1. Acne (skin problems that cause pimples)
  2. Decreased appetite
  3. Dyspnoea (difficult or laboured respiration)
  4. Feeding disorder (when children refuse to eat certain food groups)
  5. Mobility decreased (ability to move is reduced)
  6. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  7. Nerve compression
  8. Pain in jaw
  9. Peripheral swelling
  10. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

What are the common drug interactions of Synjardy and Morphine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hypokalaemia (low potassium)
  2. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  3. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Transaminases increased
  6. Scrotal abscess (pus in scrotum)

50-59:

  1. Constipation
  2. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)

60+:

  1. Vomiting
  2. Acne (skin problems that cause pimples)
  3. Dyspnoea (difficult or laboured respiration)
  4. Feeding disorder (when children refuse to eat certain food groups)
  5. Mobility decreased (ability to move is reduced)
  6. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  7. Nerve compression
  8. Pain in jaw
  9. Peripheral swelling
  10. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

What are the existing conditions these people have? *

  1. Diabetes: 8 people, 50.00%
  2. Type 2 Diabetes: 5 people, 31.25%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 12.50%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 12.50%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
  6. Depression: 2 people, 12.50%
  7. Weight Decreased: 1 person, 6.25%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.25%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 6.25%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Synjardy and Morphine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Synjardy and Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Synjardy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Synjardy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Morphine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on empagliflozin; metformin hydrochloride and morphine sulfate (the active ingredients of Synjardy and Morphine, respectively), and Synjardy and Morphine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: